DiaMedica Therapeutics Inc.

DMACNasdaqCIK 1401040HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 125 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

DiaMedica Therapeutics Inc., Reports and events
Filed	Form	What it is	Accession number
2023-05-1516:32 ET	10-Q	Quarterly reportPeriod 2023-03-31	0001437749-23-014616
2023-05-1516:31 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001437749-23-014610
2023-04-0407:02 ET	DEF 14A	Proxy statementPeriod 2023-05-17	0001437749-23-009169
2023-03-2816:31 ET	10-K	Annual reportPeriod 2022-12-31	0001437749-23-008189
2023-03-2816:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001437749-23-008188
2023-03-1016:43 ET	8-K	7.01 Regulation FD disclosure	0001437749-23-006195
2023-03-1008:00 ET	8-K/A	5.02 Departure or appointment of officers or directors	0001437749-23-006083
2023-03-0608:30 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001437749-23-005471
2022-11-0916:21 ET	10-Q	Quarterly reportPeriod 2022-09-30	0001437749-22-026609
2022-11-0916:20 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001437749-22-026608
2022-10-2616:30 ET	8-K	2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001437749-22-024801
2022-08-1117:37 ET	10-Q	Quarterly reportPeriod 2022-06-30	0001437749-22-019848
2022-08-1017:22 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001437749-22-019840
2022-07-0616:30 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001437749-22-016730
2022-06-2916:30 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001437749-22-016176
2022-05-2516:49 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001437749-22-013555
2022-05-1917:00 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001437749-22-013082
2022-05-0416:44 ET	10-Q	Quarterly reportPeriod 2022-03-31	0001437749-22-010876
2022-05-0416:41 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001437749-22-010872
2022-04-0506:03 ET	DEF 14A	Proxy statementPeriod 2022-05-18	0001437749-22-008264
2022-03-1417:01 ET	10-K	Annual reportPeriod 2021-12-31	0001437749-22-006163
2022-03-1416:58 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001437749-22-006162
2022-02-1116:16 ET	8-K	8.01 Other events	0001437749-22-003142
2021-11-1016:35 ET	10-Q	Quarterly reportPeriod 2021-09-30	0001437749-21-026175
2021-11-1016:34 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001437749-21-026172
2021-09-2708:45 ET	8-K	1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits	0001437749-21-022654
2021-09-1316:31 ET	8-K	7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001437749-21-022033
2021-08-1116:31 ET	10-Q	Quarterly reportPeriod 2021-06-30	0001437749-21-019480
2021-08-1116:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001437749-21-019477
2021-07-1608:30 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results	0001437749-21-017038
2021-06-2907:01 ET	8-K	7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001437749-21-015877
2021-06-0316:15 ET	DEF 14A	Proxy statementPeriod 2021-07-15	0001437749-21-014066
2021-05-0516:32 ET	10-Q	Quarterly reportPeriod 2021-03-31	0001437749-21-010912
2021-05-0516:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001437749-21-010911
2021-04-2916:34 ET	10-K/A	Annual report, amendedPeriod 2020-12-31	0001437749-21-010229
2021-04-2916:32 ET	8-K	8.01 Other events	0001437749-21-010228
2021-03-1016:03 ET	10-K	Annual reportPeriod 2020-12-31	0001437749-21-005541
2021-03-1016:01 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001437749-21-005540
2020-11-0416:32 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001437749-20-022537
2020-11-0416:31 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001437749-20-022536
2020-08-1116:02 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001437749-20-017514
2020-08-1116:01 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001437749-20-017512
2020-08-0720:21 ET	8-K	1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001437749-20-017105
2020-08-0516:33 ET	8-K	2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001437749-20-016685
2020-06-0316:30 ET	8-K	5.07 Shareholder vote results; 8.01 Other events	0001437749-20-012348
2020-05-1316:37 ET	10-Q	Quarterly reportPeriod 2020-03-31	0001437749-20-010599
2020-05-1316:35 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001437749-20-010597
2020-04-2007:30 ET	DEF 14A	Proxy statementPeriod 2020-06-02	0001437749-20-007997
2020-03-2316:33 ET	10-K	Annual reportPeriod 2019-12-31	0001437749-20-005906
2020-03-2316:31 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001437749-20-005905

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.